Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by InvrsContrarianon Mar 05, 2021 1:04pm
183 Views
Post# 32729282

RE:RE:Quick technical analysis of TSX,NASDAQ BIO index and SZLS

RE:RE:Quick technical analysis of TSX,NASDAQ BIO index and SZLS"I) Need confirmation"..... seems the bearish outlook is the order of the week. I don't know how things turn around, but let's say we're in this mess until the market sentiment clears up maybe the March sting from last year is playing into this. Maybe Now "March" is the new black Friday. As in March back the prices. But with the new stimulus the economy hopefully sees that the light at the end of the tunnel. Maybe the belief that no more free money is getting people into cash. Which I don't get because if the printing stops then that cash will be subject to inflation. I'd want my money working for me gaining in some sort of stock. But what do I know. I haven't survived a full in down turn. Maybe this is a little correction. But it sure hurts the portfolio. I'm making some moves... arbitrage and wotnot, but emotion rules the day even when I'm staring at massive discounts in my watchlist. But meh, I'm playing with house money so it's a free ride from here on up! Lol Glta
MarketMoney wrote:

Just keep in mind, Bio sector got 11 red days out of the last 17 trading days
SZLS got 12 red days out of the last 17 trading days

The Bio sector lost 16% ischh during that same period of time
SZLS lost 33% ischh during that same period of time

SZLS is a stock so it will fluctuate more than NASDAQ Bio index which was during that period of time 2x the index fluctuation. 

EXAS got 10 red days out of the last 17 trading days. EXAS lost 21% during that period of time.

SZLS is more volatile than EXAS as volume transaction is way superior with EXAS so more easy to move SZLS up and down with less needed volume.

Hope theses numbers will help to understand that overall markets will affect each stock. When GME got mega short squeeze, the hedge funds had to liquidate long position to cover for their loss.While doing that caused some stock to go down as they were selling huge amount of good stock to obtain the must needed cash to buyback GME shares to cover. So some stock were collateral damage because of the short squeeze on GME. Voila many things to consider when doing an analysis and it's easier to understand and keep fear aside when you see what really going on and not going for the same broken record of blaming CEO for all your problems :-)
 



<< Previous
Bullboard Posts
Next >>